Equine motor neuron disease: findings in 28 horses and proposal of a pathophysiological mechanism for the disease.
- Journal Article
Summary
The research article investigates equine motor neuron disease (EMND), a condition impacting adult horses, and sheds light on potential environmental risk factors, common symptoms, diagnostic signs, and the plausible pathophysiological mechanism of the disease. The study also presents findings from various clinical and pathological observations to support the theory that EMND is an oxidative disease.
Introduction
The research was conducted over a span of three and a half years where 28 adult horses were diagnosed with EMND. The primary purpose of the study was to better understand the environmental risks, symptoms, and the possible underlying mechanisms that pave the way for this neuronal illness in horses.
Environmental Risk Factors
- The study suggests that the most common environmental risk factors for a horse to develop EMND are the absence of grazing for more than a year and feeding on poor-quality hay.
- Interestingly, it was found that the Quarter Horse breed were 5.4 times more susceptible, which was thought to be related to the high occurrence of these horses in boarding stables.
Observations & Testing
- Horses diagnosed with EMND exhibited clinical signs like weight loss, excessive recumbency, trembling, continuous weight shifting in rear limbs, abnormal low head carriage and muscle twitching.
- Despite these symptoms, it was observed that all affected horses maintained an excellent to ravenous appetite. Some also showed a marked presence of coprophagia.
- Upon testing, an abnormally high serum concentration of muscle-derived enzymes was found consistently across all cases which may indicate muscle damage or inflammation.
- Other diagnostic signs included irregular glucose absorption, increased total protein content in cerebrospinal fluid and in some cases, intrathecal production of IgG, a type of antibody.
Treatment & Results
- Due to the inability to stand or respiratory distress, euthanasia was executed on 23 of the afflicted horses either within 4 days of hospital admission or after the complete diagnosis.
- The remaining five horses were maintained for observational reasons for varying durations, extending from nine months to over two years post the appearance of clinical signs.
- These horses were allowed access to open pastures and two of them were given supplemental vitamin E as the only form of therapy.
- Four of the acutely affected horses showed noticeable clinical improvement.
Pathophysiological Mechanism
- The study proposed that EMND could be an oxidative disease evidenced by observations of type 1 muscle fiber atrophy and lipopigment accumulation within the capillary endothelium of the spinal cord in all cases.
In conclusion, the research article offers valuable insights into the disease trajectory, clinical symptoms, environmental influences, and potential mechanistic pathways associated with EMND. This investigation lays the groundwork for further research to find possible and effective therapies for horses suffering from this condition.
Cite This Article
Publication
Researcher Affiliations
- Department of Clinical Sciences, New York State College of Veterinary Medicine, Cornell University, Ithaca 14853-6401.
MeSH Terms
- Animal Feed
- Animals
- Breeding
- Electromyography / veterinary
- Female
- Horse Diseases / epidemiology
- Horse Diseases / etiology
- Horse Diseases / physiopathology
- Horses
- Male
- Motor Neuron Disease / epidemiology
- Motor Neuron Disease / etiology
- Motor Neuron Disease / physiopathology
- Motor Neuron Disease / veterinary
- Prospective Studies
- Risk Factors
- Vitamin E / blood
Citations
This article has been cited 10 times.- Harvey AM, Ramp D, Mellor DJ. Review of the Foundational Knowledge Required for Assessing Horse Welfare. Animals (Basel) 2022 Dec 1;12(23).
- Hales EN, Aleman M, Marquardt SA, Katzman SA, Woolard KD, Miller AD, Finno CJ. Postmortem diagnoses of spinal ataxia in 316 horses in California. J Am Vet Med Assoc 2021 Jun 15;258(12):1386-1393.
- Zakia LS, Palumbo MIP, Teixeira RBC, Resende LAL, Soares MP, de Oliveira-Filho JP, Amorim RM, Borges AS. Neuromyotonia in a horse. J Vet Intern Med 2019 Jan;33(1):287-291.
- Husulak ML, Lohmann KL, Gabadage K, Wojnarowicz C, Marqués FJ. Equine motor neuron disease in 2 horses from Saskatchewan. Can Vet J 2016 Jul;57(7):771-6.
- Díez de Castro E, Zafra R, Acevedo LM, Pérez J, Acosta I, Rivero JL, Aguilera-Tejero E. Eosinophilic Enteritis in Horses with Motor Neuron Disease. J Vet Intern Med 2016 May;30(3):873-9.
- Rodrigues MC, Voltarelli JC, Sanberg PR, Borlongan CV, Garbuzova-Davis S. Immunological aspects in amyotrophic lateral sclerosis. Transl Stroke Res 2012 Sep;3(3):331-40.
- El-Assaad I, Di Bari JA, Yasuda K, Divers TJ, Summers BA, de Lahunta A, Mohammed H. Differential expression of TAR DNA-binding protein (TDP-43) in the central nervous system of horses afflicted with equine motor neuron disease (EMND): a preliminary study of a potential pathologic marker. Vet Res Commun 2012 Dec;36(4):221-6.
- Mohammed HO, Starkey SR, Stipetic K, Divers TJ, Summers BA, de Lahunta A. The role of dietary antioxidant insufficiency on the permeability of the blood-brain barrier. J Neuropathol Exp Neurol 2008 Dec;67(12):1187-93.
- Mohammed HO, Divers TJ, Summers BA, de Lahunta A. Vitamin E deficiency and risk of equine motor neuron disease. Acta Vet Scand 2007 Jul 2;49(1):17.
- Cummings JF, de Lahunta A, Mohammed HO, Divers TJ, Summers BA, Valentine BA, Jackson CA. Endothelial lipopigment as an indicator of alpha-tocopherol deficiency in two equine neurodegenerative diseases. Acta Neuropathol 1995;90(3):266-72.